# Florian Solzbacher

**Type:** person
**Status:** Draft
**Confidence:** Medium
**Focus:** neuroengineering, brain-computer interfaces, medical devices, university spinouts
**Location:** Salt Lake City, UT
**Updated:** 2026-06-19

## Summary

Florian Solzbacher co-founded [Blackrock Neurotech](blackrock-neurotech.md) in 2008 with Marcus Gerhardt as a University of Utah spinout commercializing the Utah Electrode Array — the microelectrode platform invented by Richard Normann that is the most-implanted and most-studied intracortical brain-computer-interface electrode in history, with documented use in dozens of patients across more than 30,000 cumulative implantation days. In April 2024, the crypto firm Tether took a $200 million majority strategic stake in Blackrock through its Tether Evo arm.

## Impact

Solzbacher turned a decades-long University of Utah neuroengineering research program into a commercial BCI company at a time when the BCI sector barely existed commercially. The Utah Array became the foundational research tool for a generation of BCI scientists globally, which means Blackrock's commercial success is downstream of an ecosystem effect Solzbacher helped sustain. His presence in the Salt Lake City neuroengineering cluster — alongside the SCI Institute, Ripple Neuro, and Iris Biomedical — makes him a connective node for talent and research in that domain.

## What They Offer

Deep experience commercializing neural-interface hardware from a university research base; understanding of FDA IDE and PMA pathways for active implantable devices; network connections across the global BCI research community and the Utah neuroengineering cluster specifically.

## What They Are Looking For

Not known from public sources. Inference: most likely engaged with neuroengineering, hard-technology medical devices, and university spinout questions in the neural-interface space.

## Proof of Work

- Co-founded Blackrock Neurotech (2008), commercializing the Utah Electrode Array
- Led Blackrock through two decades of clinical research tool deployment across 30,000+ implantation days
- Navigated Tether Evo's $200M majority stake acquisition (April 2024)

## Good Fits

BCI founders or medical-device engineers building implantable neurotechnology; researchers moving from academic neuroengineering into commercial products; founders navigating FDA active-implant pathways.

## Public Connection Path

Blackrock Neurotech and University of Utah neuroengineering channels.

## Evidence

- [Blackrock Neurotech](blackrock-neurotech.md)

## See Also

- [Blackrock Neurotech](blackrock-neurotech.md)
- [SCI Institute](sci-institute.md)

## Open Questions

- What is Solzbacher's current operational role after the Tether Evo majority stake acquisition?
- Is he still active at the University of Utah in an advisory or research capacity?